Cell Therapy Analytical Development Summit Europe Partners
Solvias is a world leader in contract research, development and manufacturing. We support our customers across the pharmaceutical, biotech and medical device industries. Our integrated services span all stages of drug development including custom synthesis of drug product.
We have built a solid reputation for the characterization and analysis of monoclonal antibodies, therapeutic proteins and biosimilars. These cutting-edge capabilities enable Solvias to address the complex challenges of advanced therapeutic medicinal products (ATMPs): vaccines, cell and gene therapeutics, as well as nucleic acid-based products.
Agilent is a global leader in life science, diagnostics and analytical laboratory technologies. Leveraging more than 50 years of expertise, we create instruments, software, services and solutions that provide trusted answers to our customers’ most critical questions. We are passionate about helping them solve their most ambitious scientific challenges, increase laboratory performance, and advance the quality of life.
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure, characterize, and predict our resistance and response to new therapies. Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. The company's Tapestri Platform is being utilized by customers at leading research centers, pharmaceutical, and diagnostics companies worldwide. A Tapestri assay recently entered GMP qualification and validation, indicating that single-cell analysis is on its way to routine use in clinical trials to support the next wave of life-saving CGT treatments.